Neil Dalvie | AIChE

Important Notice: Limited Web Access September 17 to 19, 2021

AIChE will undertake a routine upgrade of our digital infrastructure this weekend between 4pm ET Friday afternoon and 4pm ET Sunday afternoon. During this period access to all services that require login or payment will be limited.

Neil Dalvie

Neil Dalvie is a graduate student in Chemical Engineering at MIT. He received his B.S. (2016) in Chemical Engineering from Northwestern University, where he worked on design principles for modular metabolite biosensors in bacteria. 

At MIT, Neil applies tools from synthetic biology to enable low-cost manufacturing of therapeutic proteins in yeast. He established a platform for rapid, rational engineering of subunit vaccine antigens. This work culminated in a COVID-19 vaccine candidate for low-income countries that is in clinical development. In parallel, Neil developed genome editing tools in the industrial yeast Pichia pastoris, which enabled “fit-for-purpose” strains for the low-cost production of complex therapeutics like monoclonal antibodies. 

In the pandemic, Neil designed and instructed a new Chemical Engineering elective course on the Design and Development of Immunotherapies. He has mentored undergraduate students, professional research staff, and graduate students. Outside of the lab, Neil is an avid basketball and foosball player.